Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tamoxifen-induced venothromboembolic events: exploring validation of putative genetic association.

Clinical medicine & research - 1 Feb 2013

Glurich Ingrid, Chyou Po-Huang, Engel Jessica M, Cross Deanna S, Onitilo Adedayo A

Abstract excerpt

OBJECTIVE: A pilot study to examine accrual rates, efficiency of data capture approaches, study design and genotyping capacity for a future genetic validation study was undertaken. DESIGN: The process pilot evaluated feasibility of applying a matched case-control design to validate association of two candidate estrogen receptor (ER) single nucleotide polymorphisms (SNPs) with incidence of venothromboembolic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Incidence
Share to Linear Models

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pilot Projects

Share to Receptors, Estrogen

Share to Tamoxifen

Share to Venous Thromboembolism

Share to Wisconsin

Source

Open in PubMed Open full text

Identifiers

PMID: 23411630
DOI: 10.3121/cmr.2012.1101
PMCID: PMC3573089

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tamoxifen-induced venothromboembolic events: exploring validation of putative genetic association.PMID 23411630Read ↗

Venous thromboembolism and ovarian cancer risk: a Mendelian randomized studySemantic proximity Read ↗

Estrogen receptor genotype is associated with risk of venous thromboembolism during tamoxifen therapy.Semantic proximity Read ↗

Pharmacogenetics of Aromatase Inhibitors in Endocrine Responsive Breast Cancer: Lessons Learnt from Tamoxifen and CYP2D6 Genotyping.Semantic proximity Read ↗

Genome-wide investigation of exogenous female hormones, genetic variation, and venous thromboembolism risk.Semantic proximity Read ↗

Germline variants in the CYP19A1 gene are related to specific adverse events in aromatase inhibitor users: a substudy of Dutch patients in the TEAM trial.Semantic proximity Read ↗

HORMONE EXPOSURE AND VENOUS THROMBOEMBOLISM IN COMMERCIALLY-INSURED WOMEN 50 TO 64 YEARS OF AGESemantic proximity Read ↗

Enhancing uterine fibroid research through utilization of biorepositories linked to electronic medical record data.Semantic proximity Read ↗

DNA microarray-based analysis of single nucleotide polymorphisms may be useful for assessing the risks and benefits of hormone therapy.Semantic proximity Read ↗

Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptives.Semantic proximity Read ↗

A model for predicting age at menopause in white women.Semantic proximity Read ↗

Estrogen receptor alpha polymorphism and venous thromboembolism in male and female: data from the EDITH study.Semantic proximity Read ↗

Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.